Gujarat Themis Biosyn (GUJTHEM) Share Price Falls 5.18% Today; Stock Trades Below 50 DMA
- September 28, 2026
- Posted by: Harsh Piplani
- Category: News
Gujarat Themis Biosyn Share Price fell to Rs 395.7 today, down 5.18% from the previous close, with a market capitalisation of Rs 5,431.23 crore. The move places Gujarat Themis Biosyn in the Mid Cap category and makes today’s decline relevant for investors following Gujarat Themis Biosyn Share Price Today, Gujarat Themis Biosyn Stock News and Gujarat Themis Biosyn Share Price Update. The supplied data confirms the price event, but it does not establish a company-specific catalyst. In that setting, Univest is tracking the move through price action, valuation and sector comparison so readers can place the decline in context rather than read too much into a single session. The stock’s current price, day range and company ratios offer a factual base for Gujarat Themis Biosyn Share Price analysis.
Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 395.7 |
| Previous Close | Rs 417.3 |
| Today's Move | -Rs 21.60 (-5.18%) |
| Open | Rs 415.25 |
| High | Rs 415.25 |
| Low | Rs 395.1 |
| Turnover | Rs 0.87 crore |
| Market Capitalisation | Rs 5,431.23 crore |
| Market Cap Category | Mid Cap |
Gujarat Themis Biosyn Share Price today shows a clear same-day decline from Rs 417.3 to Rs 395.7, a fall of Rs 21.6 or 5.18%. The stock opened at Rs 415.25, which was also the day high, and then moved to a day low of Rs 395.1. That leaves the close close to the lower end of the session range, but the supplied data only confirms the day’s price path; it does not state why the move happened. The turnover was Rs 0.87 crore, which is a factual traded-value figure and should be read as context only. With a market capitalisation of Rs 5,431.23 crore, Gujarat Themis Biosyn remains a Mid Cap company. For readers searching Gujarat Themis Biosyn Share Price Fall or Gujarat Themis Biosyn Stock Falling Today, the key fact is that the stock ended below both its open and previous close. From here, the next step is to examine whether the move sits inside a broader valuation story in Gujarat Themis Biosyn Stock Analysis and Gujarat Themis Biosyn Share Price Today coverage.
Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,431.23 crore |
| P/E Ratio | 111.55x |
| P/B Ratio | 5.18x |
| ROE | 17.41% |
| ROCE | 18.16% |
| EPS | Rs 3.74 |
| Book Value Per Share | Rs 80.59 |
| Dividend Yield | 0.16% |
Gujarat Themis Biosyn has a market capitalisation of Rs 5,431.23 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 111.55x, P/B at 5.18x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.41% and ROCE of 18.16%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.74, book value per share of Rs 80.59, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.48%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 111.55x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 49.63x |
| Benchmark P/E Range | 3.46x to 735.85x |
| Company P/B Ratio | 5.18x |
| Benchmark Median P/B | 2.85x |
| Benchmark Average P/B | 4.33x |
| Company ROE | 17.41% |
| Benchmark Median ROE | 11.48% |
| Benchmark Average ROE | 10.04% |
| Company ROCE | 18.16% |
| Benchmark Median ROCE | 13.17% |
| Benchmark Average ROCE | 12.82% |
| Company Market Capitalisation | Rs 5,431.23 crore |
| Benchmark Median Market Cap | Rs 732.57 crore |
| Benchmark Average Market Cap | Rs 14,043.26 crore |
In the Healthcare sector and Pharmaceuticals & Drugs industry, Gujarat Themis Biosyn Share Price can be compared with a benchmark set of 204 companies in the same industry. The company’s P/E of 111.55 is above the benchmark median of 32.87 and above the benchmark average of 49.63. Its P/B of 5.18 is also above the benchmark median of 2.85 and above the average of 4.33. On profitability, ROE of 17.41% is above the industry median of 11.48% and the average of 10.04%, while ROCE of 18.16% is above the median of 13.17% and average of 12.82%. The industry market-cap median is Rs 732.57 crore and the average is Rs 14,043.26 crore, while Gujarat Themis Biosyn Market Cap is Rs 5,431.23 crore. That places Gujarat Themis Biosyn in the middle of the industry by size, but not by valuation. For sector analysis on Univest, the important point is that the price fall today sits against a backdrop of higher-than-benchmark valuation multiples and stronger-than-benchmark profitability ratios.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,44,716.74 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,55,115.31 | 87.22 | 14.44 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,89,613.38 | 86.94 | 21.13 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,19,899.96 | 26.57 | 4.45 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,875.68 | 33.49 | 3.21 | 11.83 | 16 |
Peer comparison helps frame Gujarat Themis Biosyn Share Price against other listed pharmaceuticals names. Sun Pharmaceutical Industries has a P/E of 36.77 and market cap of Rs 4,44,716.74 crore, while Divi’s Laboratories trades at 87.22 times earnings with a Rs 2,55,115.31 crore market cap. Torrent Pharmaceuticals shows a P/E of 86.94 and a larger P/B of 21.13. Zydus Lifesciences has a P/E of 26.57 and a P/B of 4.45, both well below Gujarat Themis Biosyn’s 111.55 and 5.18. Among the supplied peers, Gujarat Themis Biosyn is much smaller than the large-cap comparables but has a much richer earnings multiple than several names in the same industry. For Gujarat Themis Biosyn Share Price analysis, that difference matters because today’s fall comes while the company still trades at a premium to many healthcare peers on P/E and P/B.
Why Investors Are Watching Gujarat Themis Biosyn
- Gujarat Themis Biosyn Share Price fell 5.18% today to Rs 395.7.
- The stock opened at Rs 415.25 and touched a day low of Rs 395.1.
- Market capitalisation stands at Rs 5,431.23 crore and the company is classified as Mid Cap.
- P/E is 111.55, P/B is 5.18, ROE is 17.41% and ROCE is 18.16%.
- In the same industry, the benchmark median P/E is 32.87 and the benchmark median P/B is 2.85.
About Gujarat Themis Biosyn
Gujarat Themis Biosyn operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied dataset identifies the company through its listed market profile, valuation ratios and return metrics, which are the key facts used in this article. For readers following Gujarat Themis Biosyn Company News and Gujarat Themis Biosyn Stock Performance, the most relevant verified points today are the current share price, market cap, earnings multiple and return ratios. Univest uses these company facts to keep the coverage tied to disclosed data rather than to assumptions. In practical terms, Gujarat Themis Biosyn Share Price becomes easier to read when it is assessed alongside the company’s sector classification, market capitalisation and peer benchmark context.
Track Gujarat Themis Biosyn Share Price on Univest
Use Gujarat Themis Biosyn (GUJTHEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Gujarat Themis Biosyn Share Price on Univest for live price updates, company ratios, shareholding pattern, sector context, 52-week levels and market insights. Univest also brings together Gujarat Themis Biosyn Share Price Today, Gujarat Themis Biosyn Stock News and Gujarat Themis Biosyn Stock Analysis in one place so investors can review the latest factual data quickly.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Gujarat Themis Biosyn Share Price fall today?
Ans. The supplied data confirms that Gujarat Themis Biosyn Share Price fell 5.18% today to Rs 395.7, but it does not establish a company-specific catalyst. The decline is best read through the day’s price action and valuation metrics.
What is Gujarat Themis Biosyn Share Price today?
Ans. Gujarat Themis Biosyn Share Price today is Rs 395.7. It moved down from the previous close of Rs 417.3, with a decline of Rs 21.6 during the session. Market capitalisation stands at Rs 5,431.23 crore.
What does Gujarat Themis Biosyn Share Price tell investors?
Ans. Gujarat Themis Biosyn Share Price shows a same-day decline, while the company still carries a P/E of 111.55, P/B of 5.18, ROE of 17.41% and ROCE of 18.16%. Those figures add important valuation context.
How does Gujarat Themis Biosyn compare with healthcare peers?
Ans. Gujarat Themis Biosyn trades at a higher P/E and P/B than peers such as Zydus Lifesciences and Cipla, while its market capitalisation is much smaller than Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals.
What are the key fundamentals behind Gujarat Themis Biosyn Share Price?
Ans. The key fundamentals are market capitalisation of Rs 5,431.23 crore, EPS of Rs 3.74, book value of Rs 80.59 and dividend yield of 0.16%. The company also reports ROE of 17.41% and ROCE of 18.16%.
What should readers monitor next for Gujarat Themis Biosyn Share Price?
Ans. Readers should monitor the next disclosed price move, any fresh company updates, and whether the stock continues to trade at a premium valuation relative to the same-industry benchmark. Univest will continue to track the factual market data.
